AI-Driven Genotype Prediction Using EHR and Multimodal Data
Predicting Patient Genotypes Using Electronic Health Records and Multimodal Data Through AI-Based Models
The Eye Hospital of Wenzhou Medical University
100,000 participants
Jul 1, 2023
OBSERVATIONAL
Conditions
Summary
The goal of this clinical study is to explore the potential of using electronic health records (EHR) and multimodal data (such as imaging, lab results, and clinical history) to predict a patient's genotype. The study will evaluate whether predictive models based on this non-genetic data can accurately infer genetic information, which traditionally requires direct genetic testing.
Eligibility
Inclusion Criteria5
- Participants must have comprehensive electronic health records (EHR), including medical history, lab results, and relevant imaging data (e.g., X-rays, MRIs, CT scans).
- Participants must have existing genetic testing data available for comparison, if applicable.
- Participants must be willing to provide consent for the use of their health data in the study.
- Participants must have no active intervention related to genetic testing or prediction during the study period.
- Participants should have complete and verifiable health data to allow for accurate prediction by the AI model.
Exclusion Criteria3
- Participants without available EHR, lab results, or imaging data.
- Participants with ambiguous, inaccurate, or unverifiable genetic testing results that cannot be used for comparison.
- Patients with significant discrepancies or missing data that would prevent the AI model from making accurate predictions.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention in this study involves an AI-based predictive model designed to analyze and integrate patient electronic health records (EHR), clinical lab results, and multimodal imaging data (e.g., X-rays, MRIs, CT scans). The AI model is trained to predict a patient's genotype based on these non-genetic data sources. This model uses machine learning algorithms to detect patterns and infer genetic information that would traditionally require direct genetic testing. There are no active treatments or genetic tests involved in this intervention; rather, the AI system serves as a tool to predict genetic information from available clinical data, offering a non-invasive and potentially more accessible alternative to genetic testing.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06791421